| Literature DB >> 24517452 |
Jacklin F Mosha1, Hugh J W Sturrock, Brian Greenwood, Colin J Sutherland, Nahla B Gadalla, Sharan Atwal, Simon Hemelaar, Joelle M Brown, Chris Drakeley, Gibson Kibiki, Teun Bousema, Daniel Chandramohan, Roland D Gosling.
Abstract
BACKGROUND: Within affected communities, Plasmodium falciparum infections may be skewed in distribution such that single or small clusters of households consistently harbour a disproportionate number of infected individuals throughout the year. Identifying these hotspots of malaria transmission would permit targeting of interventions and a more rapid reduction in malaria burden across the whole community. This study set out to compare different statistical methods of hotspot detection (SaTScan, kernel smoothing, weighted local prevalence) using different indicators (PCR positivity, AMA-1 and MSP-1 antibodies) for prediction of infection the following year.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24517452 PMCID: PMC3932034 DOI: 10.1186/1475-2875-13-53
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Location of study site within Tanzania (inset map) and clustering of malaria infection using different methods. (A) derived from SaTScan (coldspot significantly lower infection, hotspot significantly greater infection), (B) derived from Kernel and (C) derived from Weighted Local Prevalence.
Age-dependency of malaria in the baseline and follow-up surveys
| 0-4 | 788 [27.5] | | 1 | <0.001 | |
| | 5-9 | 622 [47.9] | | 2.80 [2.17-3.62] | <0.001 |
| | 10-15 | 413 [50.1] | | 3.26 [2.44-4.35] | 0.005 |
| | 16-25 | 409 [33.7] | | 1.52 [1.13-2.04] | 0.721 |
| | 26-35 | 328 [26.5] | | 0.94 [0.68-1.30] | 0.007 |
| | 36+ | 496 [20.6] | | 0.66 [0.49-0.89] | |
| 0-4 | 824 [42.4] | | 1 | <0.001 | |
| | 5-9 | 644 [68.8] | | 4.77 [3.52-6.47] | <0.001 |
| | 10-15 | 359 [70.2] | | 5.58 [3.84-8.10] | <0.001 |
| | 16-25 | 445 [52.8] | | 1.96 [1.41-2.73] | 0.661 |
| | 26-35 | 337 [44.8] | | 1.08 [0.75-1.56] | 0.393 |
| | 36+ | 637 [39.7] | | 0.87 [0.63-1.20] | |
| 0-4 | 688 [21.7] | | 1 | <0.001 | |
| | 5-9 | 517 [53.0] | | 5.13 [3.84-6.86] | <0.001 |
| | 10-15 | 321 [64.2] | | 8.87 [6.29-12.50] | <0.001 |
| | 16-25 | 354 [60.2] | | 7.60 [5.47-10.56] | <0.001 |
| | 26-35 | 294 [51.0] | | 4.60 [3.29-6.42] | <0.001 |
| | 36+ | 416 [50.5] | | 4.39 [3.24-5.96] | |
| 0-4 | 698 [14.5] | | 1 | 0.111 | |
| | 5-9 | 568 [16.9] | | 1.31 [0.94-1.84] | <0.001 |
| | 10-15 | 346 [30.6] | | 3.21 [2.24-4.59] | <0.001 |
| | 16-25 | 361 [34.9] | | 3.90 [2.75-5.51] | <0.001 |
| | 26-35 | 291 [38.5] | | 4.90 [3.39-7.07] | <0.001 |
| 36+ | 447 [40.3] | 5.10 [3.66-7.10] |
*age was missing for one individual.
Odds of testing positive for infection during the follow-up survey: results from three geospatial models defined by baseline infection, anti-AMA-1 antibody prevalence, and anti MSP-1 antibody prevalence adjusted for age
| | | | | | |
| Neg | 1,763 | 827 [46.9] | 1 | <0.001 | 0.560 |
| Pos | 905 | 521 [57.6] | 1.58 [1.31-1.83] | | |
| | | | | | |
| 792 | 319 [40.3] | 1 | 0.181 | 0.620 | |
| coldspot | 1,728 | 864 [50.0] | 1.35 [0.87-2.09] | <0.001 | 0.628 |
| neither | 726 | 500 [68.9] | 4.54 [2.68-7.72] | 0.966 | 0.597 |
| hotspot | 804 | 390 [48.5] | 1 | 0.013 | |
| 819 | 387 [47.2] | 0.99 [0.60-1.64] | <0.001 | | |
| <14.9 | 818 | 331 [40.5] | 0.53 [0.32-0.88] | 0.165 | |
| 15-21.3 | 805 | 575 [71.4] | 3.45 [2.06-5.75] | 0.042 | |
| 21.4-27.1 | 816 | 420 [51.5] | 1 | 0.003 | |
| >27.1 | 794 | 344 [43.3] | 0.69 [0.41-1.16] | | |
| 807 | 372 [46.1] | 0.58 [0.35-0.98] | | | |
| <18.9 | 799 | 520 [65.1] | 2.21 [1.31-3.73] | | |
| 19-23.2 | | | | | |
| 23.3-26.5 | | | | | |
| >26.5 | | | | | |
| | | | | | |
| No | 1,262 | 594 [47.1] | 1 | <0.001 | 0.554 |
| Yes | 1,071 | 593 [55.4] | 1.45 [1.21-1.72] | | |
| | | | | | |
| 904 | 310 [34.3] | 1 | <0.001 | 0.647 | |
| coldspot | 1,092 | 554 [50.7] | 2.65 [1.69-4.15] | <0.001 | 0.618 |
| neither | 1,250 | 819 [65.5] | 5.84 [3.75-9.10] | 0.002 | 0.609 |
| hotspot | 814 | 308 [37.8] | 1 | <0.001 | |
| 813 | 414 [50.9] | 2.26 [1.35-3.79] | <0.001 | | |
| <27.9 | 812 | 425 [52.3] | 2.62 [1.57-4.39] | 0.154 | |
| 28-38.9 | 807 | 536 [66.4] | 5.16 [3.06-8.69] | <0.001 | |
| 39-53.0 | 804 | 325 [40.4] | 1 | <0.001 | |
| >53.0 | 809 | 357 [44.1] | 1.45 [0.86-2.44] | | |
| 800 | 476 [59.5] | 3.50 [2.07-5.91] | | | |
| <18.9 | 803 | 498 [62.0] | 3.33 [1.97-5.62] | | |
| 19-23.9 | | | | | |
| 24 -26.9 | | | | | |
| >26.9 | | | | | |
| | | | | | |
| No | 1,730 | 924 [53.4] | 1 | 0.196 | 0.541 |
| Yes | 681 | 341 [50.1] | 0.88 [0.73-1.06] | | |
| | | | | | |
| 1,703 | 992 [58.2] | 1 | 0.040 | 0.591 | |
| coldspot | 967 | 493 [51.0] | 0.64 [0.41-0.98] | <0.001 | 0.622 |
| neither | 576 | 198 [34.0] | 0.21 [0.13-0.34] | 0.773 | 0.625 |
| hotspot | 806 | 418 [51.9] | 1 | 0.008 | 0.631 |
| 835 | 440 [52.7] | 1.08 [0.65-1.78] | <0.001 | | |
| <12.9 | 808 | 538 [66.6] | 2.02 [1.21-3.38] | 0.715 | |
| 13-17.3 | 797 | 287 [36.0] | 0.34 [0.20-0.55] | 0.006 | |
| 17.4-25.4 | 805 | 415 [51.6] | 1 | <0.001 | |
| >25.4 | 813 | 430 [52.9] | 1.10 [0.66-1.81] | | |
| 802 | 533 [66.5] | 2.08 [1.23-3.51] | | | |
| <16.5 | 796 | 278 [34.9] | 0.35 [0.21-0.57] | | |
| 16.6-18.3 | | | | | |
| 18.4-22.7 | | | | | |
| >22.7 | | | | | |
| | | | | | |
| No | 986 | 253 [25.6] | 1 | 0.986 | 0.530 |
| Yes | 1,237 | 466 [37.7] | 1.00 [0.78-1.29] | | |
| | | | | | |
| - | 400 [48.4] | - | - | - | |
| coldspot | - | 357 [44.6] | - | - | 0.604 |
| neither | - | 386 [47.0] | - | - | 0.530 |
| hotspot | 827 | 540 [67.8] | 1 | 0.082 | |
| 800 | 402 [49.3] | 0.63 [0.37 - 1.07] | 0.310 | | |
| <44.5 | 822 | 380 [47.4] | 0.77 [0.46-1.28] | 0.001 | |
| 44.6-51.4 | 797 | 372 [45.6] | 2.44 [1.44-4.14] | 0.507 | |
| 51.5-59.3 | 816 | 502 [64.0] | 1 | 0.063 | |
| >59.4 | 801 | | 0.84 [0.49-1.42] | 0.023 | |
| 815 | | 0.60 [0.36-1.03] | | | |
| <16.5 | 784 | | 1.86 [1.09-3.18] | | |
| 16.6-18.3 | | | | | |
| 18.4-22.7 | | | | | |
| >22.7 |
*Only individuals who were tested at both baseline and year 1.
Figure 2Clustering of sero-positivity to AMA-1 in 2010 using SaTScan and kernel Method. Clustering of sero-positivity to AMA-1 in 2010 using (A) SaTScan and (B) kernel with a 1 km radius.
Sensitivity analysis of kernel and SaTScan analysis of PCR and serology prevalence for prediction of infection in the second year
| | |||||||
|---|---|---|---|---|---|---|---|
| | |||||||
| 0.612 | 0.622 | 0.611 | 0.628 | 0.593 | 0.616 | 0.620 | |
| | | | | | | | |
| 30.1% | 30.2% | 33.1% | 34.2% | 27.1% | 29.7% | 29.7% | |
| 23.4% | 22.7% | 25.2% | 24.8% | 20.3% | 22.4% | 22.4% | |
| 0.583 | 0.587 | 0.619 | 0.618 | 0.602 | 0.615 | 0.647 | |
| | | | | | | | |
| 26.6% | 29.0% | 31.8% | 31.9 | 9.7% | 28.9% | 48.3% | |
| 22.6% | 24.9% | 24.8 | 24.9 | 6.72% | 22.6% | 38.0% | |
| 0.559 | 0.533 | 0.602 | 0.622 | 0.595 | 0.612 | 0.591 | |
| | | | | | | | |
| 22.7% | 22.8% | 19.6% | 17.1% | 9.4% | 11.8% | 12.0% | |
| 24.9% | 24.6% | 24.5% | 24.5% | 13.7% | 17.7% | 17.8% | |
| 0.575 | 0.580 | 0.585 | 0.604 | - | - | - | |
| | | | | | | | |
| 28.7% | 30.8% | 31.1% | 32.6% | | | | |
| 24.6% | 24.7% | 24.9% | 24.5% | ||||
΅ Proportion of total nPCR positives in the second year that are found in the highest quartile.